Related references
Note: Only part of the references are listed.Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo
Alja Zottel et al.
CANCERS (2023)
Cancer stem cells: Recent insights and therapies
Hongyu Zhou et al.
BIOCHEMICAL PHARMACOLOGY (2023)
EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin?
Azamat Akhmetkaliyev et al.
MOLECULAR CANCER (2023)
Vimentin is required for tumor progression and metastasis in a mouse model of non-small cell lung cancer
Alexandra L. L. Berr et al.
ONCOGENE (2023)
Tumor heterogeneity: preclinical models, emerging technologies, and future applications
Marco Proietto et al.
FRONTIERS IN ONCOLOGY (2023)
Cancer cell plasticity during tumor progression, metastasis and response to therapy
Andrea Perez-Gonzalez et al.
NATURE CANCER (2023)
Comprehensive landscape of resistance mechanisms for neoadjuvant therapy in esophageal squamous cell carcinoma by single-cell transcriptomics
Yushang Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)
Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy
Yuanzhuo Gu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2023)
Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells
Razie Amraei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Vimentin and cytokeratin: Good alone, bad together
Nick A. Kuburich et al.
SEMINARS IN CANCER BIOLOGY (2022)
Extracellular Vimentin as a Target Against SARS-CoV-2 Host Cell Invasion
Lukasz Suprewicz et al.
SMALL (2022)
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Jian Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy
Judy R. van Beijnum et al.
NATURE COMMUNICATIONS (2022)
Cancer Vaccination against Extracellular Vimentin Efficiently Adjuvanted with Montanide ISA 720/CpG
Karlijn van Loon et al.
CANCERS (2022)
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Yuhe Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Cellular and molecular mechanisms of plasticity in cancer
Stefan R. Torborg et al.
TRENDS IN CANCER (2022)
Regulatory mechanisms and clinical significance of vimentin in breast cancer
Zhilong Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Drug resistance and Cancer stem cells
Yuan Li et al.
CELL COMMUNICATION AND SIGNALING (2021)
Selection and Characterization of Vimentin-Binding Aptamer Motifs for Ovarian Cancer
Andrea M. Costello et al.
MOLECULES (2021)
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale et al.
NATURE MEDICINE (2021)
A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases
Zhizhen Li et al.
MBIO (2021)
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Saima Usman et al.
CANCERS (2021)
Vimentin regulates the assembly and function of matrix adhesions
Zofia Ostrowska-Podhorodecka et al.
WOUND REPAIR AND REGENERATION (2021)
New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
Junsha An et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A Small Vimentin-Binding Molecule Blocks Cancer Exosome Release and Reduces Cancer Cell Mobility
Jianping Wu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Post-translational modifications soften vimentin intermediate filaments
Julia Kraxner et al.
NANOSCALE (2021)
Cancer stem-like cells with hybrid epithelial/mesenchymal phenotype leading the collective invasion
Qianghua Quan et al.
CANCER SCIENCE (2020)
A dominant vimentin variant causes a rare syndrome with premature aging
Benjamin Cogne et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2020)
Selection of Aptamers Against Vimentin for Isolation and Release of Circulating Tumor Cells Undergoing Epithelial Mesenchymal Transition
Yuan Zheng et al.
ANALYTICAL CHEMISTRY (2020)
Circular RNA circTUBGCP3 Is Up-Regulated and Promotes Cell Proliferation, Migration and Survivability via Sponge mir-30b in Osteosarcoma
Yining Xu et al.
ONCOTARGETS AND THERAPY (2020)
Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial-mesenchymal transitions and facilitates early metastasis
Marie-Emilie Francart et al.
ONCOGENE (2020)
MicroRNA-17-5p regulates EMT by targeting vimentin in colorectal cancer
Tae Won Kim et al.
BRITISH JOURNAL OF CANCER (2020)
Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections
Irene Ramos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
Lia Walcher et al.
FRONTIERS IN IMMUNOLOGY (2020)
Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses
Victoria A. Brentville et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
Emily Y. Yang et al.
FRONTIERS IN ONCOLOGY (2020)
Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapy
Adriana De La Fuente et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
EMT, MET, Plasticity, and Tumor Metastasis
Basil Bakir et al.
TRENDS IN CELL BIOLOGY (2020)
Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells
Michelle Simone Clement et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
Alja Zottel et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Tumor Plasticity and Resistance to Immunotherapy
Lucas A. Horn et al.
TRENDS IN CANCER (2020)
Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI
Chien-Hui Weng et al.
ONCOGENE (2019)
The garlic compound ajoene covalently binds vimentin, disrupts the vimentin network and exerts anti-metastatic activity in cancer cells
Catherine H. Kaschula et al.
BMC CANCER (2019)
NF-κB inhibitor, BAY11-7082, suppresses M2 tumor-associated macrophage induced EMT potential via miR-30a/NF-κB/Snail signaling in bladder cancer cells
Qi Zhang et al.
GENE (2019)
Mutation-rate plasticity and the germline of unicellular organisms
Duur K. Aanen et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2019)
Intermediate Filaments as Effectors of Cancer Development and Metastasis: A Focus on Keratins, Vimentin, and Nestin
Pooja Sharma et al.
CELLS (2019)
AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
Chenjing Zhu et al.
MOLECULAR CANCER (2019)
Vimentin filaments interact with the actin cortex in mitosis allowing normal cell division
Sofia Duarte et al.
NATURE COMMUNICATIONS (2019)
Vimentin as antigenic target in autoimmunity: A comprehensive review
Aram Musaelyan et al.
AUTOIMMUNITY REVIEWS (2018)
Diversity and functional evolution of the plasminogen activator system
Rishi Kumar Jaiswal et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Targeted co-delivery of epirubicin and NAS-24 aptamer to cancer cells using selenium nanoparticles for enhancing tumor response in vitro and in vivo
Seyed Hamid Jalalian et al.
CANCER LETTERS (2018)
Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells
Hyangsoon Noh et al.
CANCER LETTERS (2018)
MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer
Jin-Won Lee et al.
CANCER SCIENCE (2018)
Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia
Sharon Wu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
miR-30 Family: A Promising Regulator in Development and Disease
Ling Mao et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Site-specific glycosylation regulates the form and function of the intermediate filament cytoskeleton
Heather J. Tarbet et al.
ELIFE (2018)
ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition
Nicolas Skrypek et al.
EPIGENETICS & CHROMATIN (2018)
Cancer stem cells as key drivers of tumour progression
Ain Zubaidah Ayob et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
A new chemotherapy agent-free theranostic system composed of graphene oxide nano-complex and aptamers for treatment of cancer cells
Amirhossein Bahreyni et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
New insights into the role of EMT in tumor immune escape
Stephane Terry et al.
MOLECULAR ONCOLOGY (2017)
A vimentin binding small molecule leads to mitotic disruption in mesenchymal cancers
Michael J. Bollong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma
Xiao-Long Li et al.
SCIENTIFIC REPORTS (2017)
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors
Concetta Di Mauro et al.
SCIENTIFIC REPORTS (2017)
The silencing effect of miR-30a on ITGA4 gene expression in vitro: an approach for gene therapy
Leila Darzi et al.
RESEARCH IN PHARMACEUTICAL SCIENCES (2017)
miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin
Lizandra Jimenez et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Oligonucleotide aptamers: potential novel molecules against viral hepatitis
Mina Mirian et al.
RESEARCH IN PHARMACEUTICAL SCIENCES (2017)
Intermediate filament dynamics: What we can see now and why it matters
Amelie Robert et al.
BIOESSAYS (2016)
Morph-X-Select: Morphology-based tissue aptamer selection for ovarian cancer biomarker discovery
Hongyu Wang et al.
BIOTECHNIQUES (2016)
Impact of Expression of Vimentin and Axl in Breast Cancer
Kimihiro Tanaka et al.
CLINICAL BREAST CANCER (2016)
MiR-548an, Transcriptionally Downregulated by HIF1α/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression
Shuai Zhu et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells
Hyangsoon Noh et al.
ONCOTARGET (2016)
Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers
Yuan Rong et al.
ONCOTARGET (2016)
Epithelial cell migration requires the interaction between the vimentin and keratin intermediate filaments
Cristina Velez-delValle et al.
SCIENTIFIC REPORTS (2016)
Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis
Saber Imani et al.
SCIENTIFIC REPORTS (2016)
The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
Kristine Raaby Jakobsen et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Surface vimentin is critical for the cell entry of SARS-CoV
Yvonne Ting-Chun Yu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2016)
MiRNA-based therapeutic intervention of cancer
Srivatsava Naidu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Upregulation of integrin β4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma
Y. Masugi et al.
LABORATORY INVESTIGATION (2015)
Involvement of urokinase in cigarette smoke extract-induced epithelial-mesenchymal transition in human small airway epithelial cells
Qin Wang et al.
LABORATORY INVESTIGATION (2015)
Upregulation of microRNA-138-5p inhibits pancreatic cancer cell migration and increases chemotherapy sensitivity
Chao Yu et al.
MOLECULAR MEDICINE REPORTS (2015)
Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human Blood
Galina S. Zamay et al.
MOLECULAR THERAPY (2015)
Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation
Ching-Yi Liu et al.
ONCOTARGET (2015)
4EBP1/eIF4E and p70S6K/RPS6 Axes Play Critical and Distinct Roles in Hepatocarcinogenesis Driven by AKT and N-Ras Proto-oncogenes in Mice
Chunmei Wang et al.
HEPATOLOGY (2015)
MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer
Yan Sun et al.
JOURNAL OF PATHOLOGY (2015)
Vimentin Regulates Neuroplasticity in Transected Spinal Cord Rats Associated with micRNA138
Bao-Jiang Qian et al.
MOLECULAR NEUROBIOLOGY (2015)
RUNX3 regulates vimentin expression via miR-30a during epithelial- mesenchymal transition in gastric cancer cells
Zhifang Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Low expression of microRNA-30c promotes invasion by inducing epithelial mesenchymal transition in non-small cell lung cancer
Zhaopeng Zhong et al.
MOLECULAR MEDICINE REPORTS (2014)
Signaling mechanisms of the epithelial-mesenchymal transition
David M. Gonzalez et al.
SCIENCE SIGNALING (2014)
DNA-Aptamer Targeting Vimentin for Tumor Therapy In Vivo
Tatyana N. Zamay et al.
NUCLEIC ACID THERAPEUTICS (2014)
Crosstalk of oncogenic signaling pathways during epithelial-mesenchymal transition
Stephan Lindsey et al.
FRONTIERS IN ONCOLOGY (2014)
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion
Jessica Bockhorn et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
miR-506 Regulates Epithelial Mesenchymal Transition in Breast Cancer Cell Lines
Himanshu Arora et al.
PLOS ONE (2013)
Investigating citrullinated proteins in tumour cell lines
Zhongmin Jiang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer
Chun-Wen Cheng et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Tumor suppressive microRNA-138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma
Takeshi Yamasaki et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines
Xiqiang Liu et al.
BIOCHEMICAL JOURNAL (2011)
Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation
Jose T. Thaiparambil et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Two Domains of Vimentin Are Expressed on the Surface of Lymph Node, Bone and Brain Metastatic Prostate Cancer Lines along with the Putative Stem Cell Marker Proteins CD44 and CD133
Nicole F. Steinmetz et al.
Cancers (2011)
Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas
J. Braun et al.
ONCOGENE (2010)
Dominant cataract formation in association with a vimentin assembly disrupting mutation
Martin Mueller et al.
HUMAN MOLECULAR GENETICS (2009)
The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells
Mugdha V. Joglekar et al.
ISLETS (2009)
Intermediate filaments in smooth muscle
Dale D. Tang
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
A dominant vimentin mutant upregulates Hsp70 and the activity of the ubiquitin-proteasome system, and causes posterior cataracts in transgenic mice
Roland Bornheim et al.
JOURNAL OF CELL SCIENCE (2008)
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis
Holger Bang et al.
ARTHRITIS AND RHEUMATISM (2007)
Towards a molecular description of intermediate filament structure and assembly
Dauid A. D. Parry et al.
EXPERIMENTAL CELL RESEARCH (2007)
The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin
Paola Bargagna-Mohan et al.
CHEMISTRY & BIOLOGY (2007)
Mutations in vimentin disrupt the cytoskeleton in fibroblasts and delay execution of apoptosis
R Schietke et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2006)
Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments
JE Eriksson et al.
JOURNAL OF CELL SCIENCE (2004)
Share Paper
